Healthcare, especially for critical illness, oftentimes feels transactional because of the burden it brings to the patient’s daily living domain – from the time of diagnosis until after hospital care. HI-Eisai Pharmaceutical, Inc. (HI-Eisai) is changing this perception by putting human connection at the core of its practice to restore trust and dignity throughout the care journey.
Such is the unique concept of Human Health Care (HHC) that HI- Eisai– a partnership between Japan’s Eisai Group and Yuchengco Group of Companies’ (YGC) House of Investments – has embraced not just as an internal philosophy, but as a binding corporate concept.
